Maryland Department of Health
Maryland Medicaid Administration

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

§1115 HealthChoice Demonstration


Proposed 2027-2031 Demonstration Period


Background

The Centers for Medicare and Medicaid Services (CMS) has authorized the Maryland Department of Health's (the Department) existing §1115 demonstration, known as the HealthChoice demonstration, through December 31, 2026. The HealthChoice demonstration authorizes Maryland’s managed care program, known as HealthChoice, as well as other innovative programs. The Department's current §1115 Demonstration Special Terms and Conditions can be found here.


§1115 Demonstration Extension Application (2025)

The Department submitted an application to extend its §1115 demonstration for a five-year period, from January 1, 2027 through December 31, 2031. Under the §1115 demonstration extension application, the Department seeks authorization to continue existing  pilots and programs, as well as seeks a technical amendment to the Increased Community Services (ICS) program eligibility requirements, which will expedite potential enrollment in ICS.

The Department accepted public comments from interested stakeholders during the 30 day public comment period between  June 30, 2025,  until July 30, 2025. To review the Department’s §1115 demonstration extension application, please click here​​. 


§1115 Demonstration Extension Resources (2025)





​​2022-2026 Demonstration Period 

Effective January 1, 2022, the Centers for Medicare & Medicaid Services (CMS) approved and extended Maryland's §1115 demonstration, known as HealthChoice, for a period of five years. The Maryland Department of Health (MDH) accepted public comments from May 4, 2021, through June 4, 2021.​

Pending CMS Approval

2022-2026 Approved

2017-2021 Demonstration Period 

Effective January 1, 2017, the Centers for Medicare & Medicaid Services (CMS) approved and extended Maryland's §1115 demonstration, known as HealthChoice, for a period of five years. The Maryland Department of Health accepted public comments from April 29, 2016, through May 31, 2016.​

2017-2021 Approved